St. Vincent's Comprehensive Cancer Center - Manhattan — New York, New York

St. Vincent's Comprehensive Cancer Center - Manhattan is a clinical research site located in New York, New York, United States 10011.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

St. Vincent's Comprehensive Cancer Center - Manhattan has participated in 9 clinical trials.

Therapeutic areas: Pancreatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Infection.

Sponsors: Theradex, Fred Hutchinson Cancer Center, Gary Morrow.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Vincent's Comprehensive Cancer Center - Manhattan?

St. Vincent's Comprehensive Cancer Center - Manhattan has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Vincent's Comprehensive Cancer Center - Manhattan conducted?

St. Vincent's Comprehensive Cancer Center - Manhattan has 9 clinical trials on record. Their work covers Pancreatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Infection.

Is St. Vincent's Comprehensive Cancer Center - Manhattan accredited by Crixeo Health?

Yes — St. Vincent's Comprehensive Cancer Center - Manhattan holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about St. Vincent's Comprehensive Cancer Center - Manhattan?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.